T itanium alloy dental implants have been designed, fabricated, and tested with microgeometries (surface characteristics in the micron range) to control bone and soft-tissue integration. These surfaces have highly oriented, consistent microstructures that are applied using computer-controlled laser ablation techniques using a pulsed, computercontrolled Excimer laser system and large-area masking. Animal experiments 1 indicate that this technology enhances bone and soft-tissue integration and controls the local microstructural geometry of attached bone.
Colonies of cells grown on the laser machined surfaces show preferential colonization parallel to the grooves. The microgrooved surfaces cause elongated colony growth, which is accelerated in the x direction (parallel to the surface microgeometry) and inhibited in the y direction (perpendicular to the surface microgeometry). On an individual cell level, the cells are observed to attach and orient along the surface grooves. This causes the cells to be "channeled" in the x direction, as compared with control cultures, where the outgrowing cells move randomly on flat surfaces. Cells are observed to attach and orient within the grooves and on flat tops of the grooves. This results in enhanced x axis growth and almost no y axis growth by cells on these surfaces; the cells are spindle shaped and well oriented. Implant chamber model studies 2 show that canine bone grows into channels lined with the laser micromachined surfaces faster and more extensively than in channels lined with blast textured surfaces. New bone is observed to attach directly to the laser micromachined surfaces and the trabecular bone adjacent to these surfaces is strongly oriented parallel to the microgrooves. This orientational effect of the laser micromachined surfaces on attached bone is confirmed in an intramedullary rod sample where orientation of attached bone trabeculae follows microgroove orientation whether it is circumferential or longi- 8 using an implant with a similar screw thread and screw surface as the implant used in this experimental study found 1.23 mm and Ͻ1 mm of bone loss, respectively.
The clinical question addressed by the study described here is as follows: Will the laser microtexturing surface treatment of the implant collar reduce crestal bone loss and establish a stable soft-tissue seal with no increase in inflammation measures such as bleeding and plaque index?
MATERIALS AND METHODS
This study evaluates the Silhouette Dental Implant (Laser-Lok (LL), Bio-Lok International, Deerfield Beach, FL) with laser microtexturing surface treatment of the implant collar (LL) versus a control tapered implant with a standard machined collar (control implant). The control implant used in this study is a tapered implant with a reverse buttress thread design and a 2 mm wide collar. The body of the implant has been roughened by blasting with a resorbable blast media. The Silhouette with laser microtexturing surface treatment has the same body design and screw area surface treatment as the control, but has a laser micromachined collar. This implant, shown in Figure 1 , has a 2 mm wide collar that has been laser micromachined in the lower 1.5 mm. The lower, 0.8 mm (bone contacting) region, has been laser grooved with 12 m wide by 10 m deep grooves that have been previously shown in preclinical studies to optimize the surface for bone attachment.
1,2 The next 0.7 mm of the collar has been laser grooved with 8 m wide by 5 m deep grooves that have been previously shown to optimize the surface for connective tissue attachment. The upper 0.5 mm of the collar, as machined, encourages epithelial tissue colonization.
Baseline Demographic Data
Clinical testing has been performed by the group for implant research in Italy. The 2 implants are compared against each other and with historical controls previously published on the Bio-Lok MicroLok implant system. 8, 9 Each patient received 2 single tooth implants, with and without laser surface treatment (LL vs control implant). All implants were restored at 4 months postoperative. The study was performed with 5 investigators and a total of 15 patients who received 20 sets of implants. The patients included 6 men and 9 women ranging in age from 42 to 69 years old with a mean age of 55.8 years. Among the 20 implant pairs, 8 were in the mandible and 12 were in the maxilla. Each patient signed a consent form indicating the experimental nature of the devices, the purpose of the study, their rights, and their obligations.
Endpoints
A comparison between means was done using t tests for all measurements and the resulting P values were recorded.
Effectiveness endpoints. The primary effectiveness endpoints are probing depth (the average of 4 measurements taken at the mesial, buccal, distal, and lingual surfaces of the implant) and crestal bone loss (average of the 2 radiographic measurements taken at the mesial and distal locations of the implant).
Safety endpoints. The safety endpoints are plaque index and sulcular bleeding index. Each of these endpoints are measured at the mesial and distal locations of the implant on a 4-point scale, with the categories of 0 (no plaque detected), 1 (plaque was noted only by running a probe across the smooth marginal surface of the implant), 2 (plaque could be seen by the naked eye), and 3 (an abundance of soft matter) for the plaque index and 0 (no bleeding when a periodontal probe was passed along the gingival margin adjacent to the implant), 1 (only isolated bleeding was visible), 2 (blood formed a confluent red line on the margin), and 3 (presence of heavy or profuse bleeding) for the sulcular bleeding index. The scores assigned to the 2 measurements were averaged to create a numeric score.
All measurements were initiated at 1-month postoperative, after soft tissue healing and were done at 2-month intervals up to 37 months.
RESULTS

Patient Accountability
No patient was lost to follow-up. In one patient (patient 1) the site implanted with the LL implant failed to osseointegrate and the implant was removed. All other implants, LL and control implant, have been followed for the full 37 months.
Effectiveness Results
X-rays for a typical case postoperatively and at 25 months are shown in Figure 2 for a 44-year-old male. The crestal bone seems to be retained around the Silhouette with laser surface treatment (LL), whereas there is noticeable bone loss evident around the implant without laser surface treatment (control implant).
The 2 primary effectiveness endpoints are probing depth and crestal bone loss. The differences between the LL and control implants were tested at each study visit by a paired t test.
As seen in Figure 3 , the LL treatment yielded consistently lower probing depth at each visit with significance for all time periods (P Ͻ 0.001). As seen in Figure 4 , LL was numerically superior to control implant in crestal bone loss at each month after month 1, and achieved nominal statistical significance at month 7 (P ϭ 0.003), and each month thereafter (P Ͻ 0.001). This difference is seen to increase numerically at each successive visit.
All 20 implant pairs were included in analyses up to 7 months, and only 19 pairs at months 9 through 37. This is because the LL implant in patient 1 failed at 7 months and the implant was removed. To conduct an intent to treat analysis, which uses all implants, a difference between treatments of zero (consistent with the null hypothesis of no effect due to the LL surface treatment) was imputed for all missing data for Patient 1 for both probing depth and crestal bone loss, and the aforementioned analyses were repeated. The resulting differences at each of the visits in which a value was imputed (months 9 -37) remained significant (P Ͻ 0.001).
A subgroup analysis was performed on the 20 pairs of implants to compare implants in the mandible with those in the maxilla. Mean differences between treatments were computed for probing depth and crestal bone loss. LL was numerically superior to the control implant at each month for implants in the mandible and implants in the maxilla, for both probing depth and crestal bone loss. However, there is no statistical significance to these data. Therefore, the data only suggest a possible greater effect of LL surface treatment on implants in the maxilla than in the mandible. 
Justification for Pooling Investigators
Five surgeons implanted between 2 and 7 pairs of implants each. To assess the poolability of the data from these 5 surgeons, the month 37 data for each of the effectiveness endpoints was analyzed by surgeon. The means for each surgeon and treatment were computed, along with the differences between treatments. The LL treatment was consistently superior to the Silhouette for each endpoint and surgeon. This consistency of treatment effect among the 5 surgeons indicates that the data are poolable.
Safety Results
The safety endpoints were plaque index and sulcular bleeding index. All individual values for each of these indices were either a 0 or a 1, hence, the resulting averages of the mesial and distal determinations were either a 0, 0.5 (one value was 0 and the other was 1), or 1. The resulting data at each visit are shown in Figures 5 and 6 , respectively. A one-sided 95% upper confidence bound on the differences in the means was computed. No statistically significant differences in the 2 data sets were found except for sulcular bleeding at 21 and 37 months where LL was superior. Generally, however, there seems to be no clinically significant safety endpoint differences between LL and control implant.
DISCUSSION
The Silhouette design implant combines proven design concepts 7, 9 (reverse buttress thread and high surface area microtextures) with a novel tapered design. 10 The Silhouette implant with LL surface treatment combines these Silhouette features with organized microtextures in critical areas. The Osseo-Lok high surface area microtexture on the threaded portion of the implant has been shown in preclinical animal testing to enhance bone apposition to the implant. 11 The LL surfaces have been shown to inhibit fibrous encapsulation, enhancing bony attachment in bony areas, enhance the formation of a softtissue seal in soft-tissue areas and control local tissue microarchitecture. 11 This combination of organized cells and organized extracellular matrix results in unique tissue formation at the interface resulting in true "endosseous incorporation." 1, 2 The bleeding index for both implants after the initial healing period ranges from 0.45 to 0.03 with no statistical difference between pairs except at 2 time points where LL is superior. The historical data from an earlier study of Bio-Lok implants presents a range from 0.00 to 0.50 with a mean of 0.25. 8, 9 The plaque index goes as high as 0.27 for the control implants and 0.25 for the LL implants with no statistical difference between pairs. The historical data had a mean plaque index of 0.27, close to the highest mean at any time period for either the LL or the control implants. These data indicate that there is no increase in these inflammation measures (bleeding and plaque indices) as compared with either prospective controls or historical data.
The consistent difference in probing depth between the implant pairs with and without the Laser microtexture surface treatment implies that a soft-tissue seal above the bone has been established in the LL implanted sites. This was demonstrated histologically in a previous canine implant study. 11 Accounting for the crestal bone loss with both implants, an ϳ1.0 to 0.7 mm probing difference is maintained throughout the study. This is approximately the height of the 8 m texturing (0.7 mm) on the LL implant.
The crestal bone loss data are the most dramatic result of this study. The LL bone loss is limited to 0.59 mm whereas the control data demonstrates up to 1.94 mm of bone loss. The data reported for other implant systems is in the range from 1.0 to 2.5 mm. 3, 6, 12 The LL surfaced implant is superior in this important measure to consecutive controls and literature reports on other implant systems.
CONCLUSIONS
The combined results of this study with preclinical animal studies 1,2,11 and analyses 13 have demonstrated that it is not necessary to accept up to 2.5 mm of crestal bone loss around dental implants as has been proposed in the literature. 3, 6, 12 At 3 years postoperative the Silhouette implant with LL surface treatment enables the reduction of crestal bone loss to 0.59 mm. It is hypothesized that this has been accomplished by reducing the stress in the crestal bone through a combination of implant design and surface modification 13 and effecting soft-tissue attachment above the bone. 11 These benefits, accomplishing true "endosseous incorporation," were demonstrated without any degradation in plaque index and sulcular bleeding index as compared with controls.
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The authors claim to have no financial interest, directly or indirectly, in any entity that is commercially related to the products mentioned in this article. ricci@nyu.edu Evaluación clínica de la microtexturización con láser de la fusión de tejido suave y hueso a implantes dentales ABSTRACTO: Propósito: Se evaluó un implante dental cónico (LL) con un cuello de 2 mm de ancho, que había sido micromaquinado con láser en los 1.5 mm más bajos para lograr la fusión del tejido conectivo preferencialmente mientras que se impedía el crecimiento epitelial hacia abajo en una prueba clínica controlada, prospectiva, realizada en varios centros. Materiales y métodos: Se informaron los datos a períodos de medición desde el 1 al 37 meses luego de la operación en 20 pares de implantes en 15 pacientes. Los implantes se colocan adyacentes a los implantes de control con cuello maquinado (C) del mismo diseño. Los valores de la medición se informaron del: índice de sangrado, índice de placa, profundidad del sondaje y pérdida del hueso crestal. Resultados: No se midieron diferencias estadísticas para el índice de sangrado o de placa. En todos los períodos de medición hubo diferencias significativas en las profundidades del sondaje y las diferencias de pérdidas del hueso crestal fueron significativas después de los 7 meses (P Ͻ 0.001). A los 37 meses, la mediana de la profundidad del sondaje es de 2.30 mm y la mediana de la pérdida crestal del hueso es 0.59 mm en LL contra un 3.60 y 1.94 mm, respectivamente, en C. Además, la comparación de los resultados en la mandíbula versus el maxilar demuestra una mayor diferencia (C menos LL) en la mediana de la pérdida de hueso crestal y la profundidad del sondaje en el maxilar. Sin embargo, este resultado no fue estadísticamente significativo. Discusión y Conclusiones: La diferencia consistente en la profundidad del sondaje entre LL y C demuestra la formación de un sello de tejido suave estable encima del hueso crestal. LL limitó la pérdida del hueso crestal alrededor de los 0.59 mm comparado con la pérdida de hueso crestal de 1,94 mm de C. Se encontró que el implante de LL es comparable al implante de C en el índice de placa de los puntos extremos y el índice de sangrado del sulcus. Existió una sugerencia no estadística-mente significativa que la superioridad de la retención del hueso crestal LL es mayor en el maxilar que en la mandíbula.
Abstract Translations GERMAN / DEUTSCH
PALABRAS CLAVES: pérdida de hueso alveolar/etiología, diseño de la próstesis dental, hueso crestal, superficie del implante Um implante dentário afunilado (LL) com colarinho de 2 mm de largura, que foi microusinado a laser no 1.5 mm inferior para realizar preferencialmente inserção de osso e tecido conjuntivo enquanto exibia migração epitelial, foi avaliado num ensaio clínico multicentro, controlado e em perspectiva. Materiais e Métodos: Os dados são relatados em períodos de medição de 1 a 37 meses após a cirurgia para 20 pares de implantes em 15 pacientes. Os implantes são colocados adjacentes a implantes de controle de colarinho usinado (C) com o mesmo projeto. Valores de medição são relatados para: Índice de Sangramento, Índice de Placa, Profundidade de Sondagem e Perda de Crista Ó ssea. Resultados: Nenhuma diferença estatística é medida para índice de sangramento ou de placa. Em todos os períodos de medição há diferenças significativas nas profundidades de sondagem e as diferenças de perda de crista óssea são significativas após 7 meses (P Ͻ 0.001). Em 37 meses a profundidade de sondagem média é 2.30 mm e a perda de crista óssea média é 0,59 mm para LL versus 3.60 mm e 1.94 mm, respectivamente, para C. Além disso, comparar resultados na mandíbula versus aqueles na maxila demonstra uma diferença maior (C menos LL) na perda de crista óssea média e profundidade de sondagem na maxila. Contudo, este resultado não foi estatisticamente significativo. Discussão e Conclusões: A diferença consistente em profundidade de sondagem entre LL e C demonstra a formação de uma vedação estável de tecido mole acima da crista óssea. LL limitou a perda de crista óssea ao intervalo de 0,59 mm em oposição à perda de crista óssea de 1,94 mm relatado para C. O implante LL foi considerado comparável ao implante C em índice de placa de parâmetros de segurança e índice de sangramento sulcal. Há uma sugestão estatisticamente não significativa de que a superioridade de retenção da crista óssea de LL é maior na maxila do que na mandíbula. 
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